secwatch.observer — SEC 8-K summary
======================================

Issuer:     APTARGROUP, INC. (ATR)
CIK:        0000896622
Form:       8-K
Filed at:   2025-10-30T23:59:59+00:00
Accession:  0000896622-25-000031
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AptarGroup Q3 2025: adj. EPS $1.62 (+4% YoY); pharma injectables surge 18%; Q4 adj. EPS guidance $1.20-$1.28
--------------------------------------------------------------------------------

- Reported sales $961M (+6% YoY); core sales +1%. Reported EPS $1.92 (+30%); adjusted EPS $1.62 (+4%).
- Pharma injectables sales surged 18% driven by GLP-1 components; Pharma core sales +2%.
- Beauty core sales flat; Closures core sales -1% due to lower tooling and resin pass-throughs.
- Q4 adjusted EPS guidance $1.20-$1.28; returned $70M to shareholders in Q3 via repurchases and dividends.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/896622/000089662225000031/0000896622-25-000031-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/896622/000089662225000031/atr-20251030.htm
  HTML page:      https://secwatch.observer/filing/0000896622-25-000031

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer